About PACB
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified D... [Read more]
Industry Medical Devices
Sector Healthcare
IPO Date Oct 27, 2010
Employees 796
Stock Exchange NASDAQ
Ticker Symbol PACB
Full Company Profile
Financial Performance
In 2023, PACB's revenue was $200.52 million, an increase of 56.29% compared to the previous year's $128.30 million. Losses were -$306.74 million, -2.39% less than in 2022.
Financial Statements
Analyst Forecast
According to 13 analysts, the average rating for PACB stock is "Buy." The 12-month stock price forecast is $7.77, which is an increase of 432.19% from the latest price.
Price Target
$7.77
(432.19% upside)
Analyst Consensus: Buy
Stock Forecasts
News
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
Announces Plan to Reduce Annualized Operating Expense Run Rate by $50 - $75 Million Q1 2024 Earnings Conference Call Scheduled for May 9, 2024 MENLO PARK, Calif. , April 16, 2024 /PRNewswire/ – PacBi...
2 days ago - PRNewsWire
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes
HiFi Data Generated on the Revio™ System will Support the EU and Estonian Government-Funded Center for Personalized Medicine and Unlock Discoveries Across Cardiology, Mental and Reproductive Health, ...
22 days ago - PRNewsWire
PacBio Grants Equity Incentive Award to New Employee
MENLO PARK, Calif., March 22, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of t...
27 days ago - PRNewsWire
Top 5 Health Care Stocks Which Could Rescue Your Portfolio In March - Inspire Veterinary (NASDAQ:IVP), Fractyl Health (NASDAQ:GUTS)
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Other symbols: GUTSIVPMTEMOM
4 weeks ago - Benzinga
PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions
HiFi Long-Read Sequencing Panel Supports Comprehensive Analysis of 20 Genes Associated With Neurological Disease MENLO PARK, Calif. , March 12, 2024 /PRNewswire/ -- PacBio(NASDAQ: PACB), a leading de...
5 weeks ago - PRNewsWire
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March - Ironwood Pharmaceuticals (NASDAQ:IRWD), Integra Lifesciences (NASDAQ:IART)
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Other symbols: IARTIRWD
6 weeks ago - Benzinga
PacBio to Present at Upcoming Investor Conferences
MENLO PARK, Calif. , Feb. 26, 2024 /PRNewswire/ --PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participati...
7 weeks ago - PRNewsWire
PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results
MENLO PARK, Calif. , Feb. 15, 2024 /PRNewswire/ --PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December31, 2023.
2 months ago - PRNewsWire
Experiential Marketing Firm VOLO Events Agency Wins Best Event Technology Award for PacBio Product Launch
ATLANTA , Feb. 13, 2024 /PRNewswire/ -- VOLO Events Agency (VOLO), a leading producer of experiential marketing and live events for global brands, has won the best Event Technology award at the BizBas...
2 months ago - PRNewsWire
PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale
New Library Preparation Solutions Offer Never Before Achieved Scale for the Revio™ Sequencing System MENLO PARK, Calif. , Feb. 5, 2024 /PRNewswire/ -- PacBio(NASDAQ: PACB), a leading developer of hi...
2 months ago - PRNewsWire
PacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024
MENLO PARK, Calif. , Jan. 25, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter 2023 financial results on Thursda...
3 months ago - PRNewsWire
PacBio Announces New Nanobind PanDNA Kit Enabling HiFi Optimized DNA Extraction Solutions
Existing HT CBB Kit Enables High-Throughput Extraction of HMW DNA Tailored for HiFi With an Updated Workflow for Animal Blood and Bacteria MENLO PARK, Calif. , Jan. 15, 2024 /PRNewswire/ -- PacBio(NA...
3 months ago - PRNewsWire
PacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectively
Ships a record number of PacBio sequencers in 2023, including 173 Revio™ systems, and announces record fourth quarter preliminary consumable revenue of $18.9 million as demand for long-read sequencing...
3 months ago - PRNewsWire
PacBio to Present at 42nd Annual J.P. Morgan Healthcare Conference
MENLO PARK, Calif. , Dec. 27, 2023 /PRNewswire/ --PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting ...
4 months ago - PRNewsWire
PacBio Announces the Retirement of David Botstein, Ph.D., from its Board of Directors
MENLO PARK, Calif. , Dec. 11, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that David Botstein, Ph.D.
4 months ago - PRNewsWire
PacBio Announces HiFi Solves, a Global Consortium of Clinical Genomics Research Leaders
Consortium Aims to Share Best Practices and Increase our Understanding of Genetic Disease MENLO PARK, Calif. , Nov. 2, 2023 /PRNewswire/ -- PacBio(NASDAQ: PACB), a leading developer of high-quality, ...
6 months ago - PRNewsWire
PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partners to PacBio Compatible
Partnerships Maximize Value of HiFi Data and Complete the Full End-to-End Workflow for PacBio Customers. MENLO PARK, Calif.
6 months ago - PRNewsWire
PacBio Announces Kinnex RNA Kits, Further Scaling HiFi Sequencing in Full-Length RNA, Single-Cell RNA and 16S rRNA Applications
Building on the MAS-Seq Concatenation Method, These Three New Kits can Significantly Increase Throughput in RNA Applications MENLO PARK, Calif. , Oct. 31, 2023 /PRNewswire/ -- PacBio(NASDAQ: PACB), a...
6 months ago - PRNewsWire
PacBio Announces Third Quarter 2023 Financial Results
MENLO PARK, Calif. , Oct. 30, 2023 /PRNewswire/ --PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2023.
6 months ago - PRNewsWire
PacBio Announces Appointment of David Meline to Board of Directors
Former CFO of Moderna, Amgen, and 3M Brings Decades of Relevant Experience to the PacBio Board MENLO PARK, Calif. , Oct. 16, 2023 /PRNewswire/ -- PacBio(NASDAQ: PACB), a leading developer of high-qua...
6 months ago - PRNewsWire
PacBio to Report Third Quarter 2023 Financial Results on October 30, 2023
MENLO PARK, Calif. , Oct. 12, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2023 financial results on Monday, ...
6 months ago - PRNewsWire
PacBio Announces Complete Computational Workflow for Human Whole Genome Sequencing Data Analysis
PacBio WGS Variant Pipeline Will Bring Standardization to PacBio HiFi Data Analysis MENLO PARK, Calif. , Oct. 11, 2023 /PRNewswire/ -- PacBio(NASDAQ: PACB), a leading developer of high-quality, highl...
6 months ago - PRNewsWire
PacBio Announces PacBio Capital
New Program Expands Access to PacBio's Highly Accurate Sequencing Systems by Providing Flexible Financing MENLO PARK, Calif. , Sept. 12, 2023 /PRNewswire/ -- PacBio(NASDAQ: PACB), a leading develop...
7 months ago - PRNewsWire
PacBio Announces Collaboration with Leading Library Preparation Automation Partners
Hamilton, Integra, Revvity, and Tecan Join PacBio Compatible to Offer Verified Automated Library Prep Workflows for Whole Genome Sequencing MENLO PARK, Calif. , Sept. 7, 2023 /PRNewswire/ -- PacBio(N...
8 months ago - PRNewsWire
PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care
Study is first of its kind to compare diagnostic rates across short- and long-read sequencing platforms MENLO PARK, Calif. and STAMFORD, Conn.
Other symbols: WGS
9 months ago - PRNewsWire
